Breaking News

Today Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Hot Stocks	Merck begins tender offer to acquire Pandion Therapeutics for $60 per share » 06:49 03/04/21 03/04 06:49 03/04/21 06:49 MRK Merck $73.30 / +0.46 (+0.63%) , PAND Pandion Therapeutics $61.62 / +0.56 (+0.92%) Merck (MRK) is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options PAND MRK PAND Pandion Therapeutics $61.62 / +0.56 (+0.92%) 02/25/21 Merck, Pandion Therapeutics deal has approx. total equity value of $1.85B 02/25/21 Merck to acquire Pandion Therapeutics for $60 per share in cash 02/22/21 Pandion Therapeutics presents preclinical data on PT001 MRK Merck $73.30 / +0.46 (+0.63%) 03/02/21 Merck to help produce Johnson & Johnson COVID-19 vaccine 03/01/21 Merck announces voluntary withdrawal for KEYTRUDA in SCLC 03/01/21 Merck: FDA accepts gefapixant New Drug Application for review 02/25/21 Merck to acquire Pandion Therapeutics for $60 per share in cash MRK PAND MRK Merck $73.30 / +0.46 (+0.63%) 02/25/21 SVB Leerink Pandion Therapeutics downgraded to Market Perform from Outperform at SVB Leerink 02/25/21 Morgan Stanley Pandion downgraded to Equal Weight from Overweight at Morgan Stanley 02/17/21 William Blair William Blair 'highly encouraged' by Nektar's collaborations with Merk, SFJ 01/21/21 Wedbush Scholar Rock price target raised to $66 from $47 at Wedbush PAND Pandion Therapeutics $61.62 / +0.56 (+0.92%) 01/04/21 Goldman Sachs Pandion's PT101 'well-positioned' vs. competitors, says Goldman Sachs 08/11/20 Fly Intel: Top five analyst initiations PAND MRK PAND Pandion Therapeutics $61.62 / +0.56 (+0.92%) 11/16/20 Pandion Therapeutics reports Q3 EPS (51c), consensus (44c) MRK Merck $73.30 / +0.46 (+0.63%) 02/04/21 Merck sees FY21 adjusted EPS $6.48-$6.68, consensus $6.41 02/04/21 Merck reports Q4 adjusted EPS $1.32, consensus $1.38 02/03/21 Notable companies reporting before tomorrow's open 17 Jul MRK MRK Merck $73.30 / +0.46 (+0.63%) 03/02/21 Merck to help produce J&J Covid vaccine, Washington Post reports 02/10/21 Merck in talks to produce authorized COVID-19 vaccines, WSJ says 02/03/21 Records show Merck's Propecia has trail of suicide reports, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says PAND MRK PAND Pandion Therapeutics $61.62 / +0.56 (+0.92%) 02/25/21 Fly Intel: Pre-market Movers MRK Merck $73.30 / +0.46 (+0.63%) 03/02/21 Fly Intel: Wall Street's top stories for Tuesday 03/02/21 Fly Intel: Wall Street's top stories at midday 02/25/21 Fly Intel: Wall Street's top stories for Thursday 02/25/21 Fly Intel: Wall Street's top stories at midday 04/09/21 Pharma/Biopharma 03/16/21 Healthcare Corporate Access Virtual Day 04/29/21 Merck - MRK 03/29/21 PDUFA Date for KEYTRUDA 04/13/21 PDUFA Date for Keytrude w/Chemotherapy 07/18/21 PDUFA Date for V114 11/28/21 PDUFA Date for KEYTRUDA (Phase 3 KEYNOTE-355 Trial) 12/21/21 PDUFA Date for Gefapixant MRK MRK Merck $73.30 / +0.46 (+0.63%) 03/02/21 Unusually active option classes on open March 2nd 02/17/21 Merck call volume above normal and directionally bullish 12/23/20 Merck call volume above normal and directionally bullish 10/20/20 Merck put volume heavy and directionally bearish

Yesterday
Recommendations	Bayer price target raised to EUR 68 from EUR 60 at Berenberg » 14:38 03/03/21 03/03 14:38 03/03/21 14:38 BAYRY Bayer $0.00 / + (+0.00%) Berenberg analyst… Berenberg analyst Sebastian Bray raised the firm's price target on Bayer to EUR 68 from EUR 60 and keeps a Buy rating on the shares. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly BAYRY Bayer $0.00 / + (+0.00%) 02/24/21 Bayer to divest Environmental Science Professional business 02/17/21 Selecta, AskBio initiate first-in-human dose escalation study of ImmTOR 02/05/21 CureVac enters pact with UK Government to develop SARS-CoV-2 variant vaccine 02/03/21 Bayer announes $2B agreement to resolve future Roundup cases BAYRY Bayer $0.00 / + (+0.00%) 03/02/21 Citi Atara Biotherapeutics upgraded to Buy at Citi following 35% pullback 03/01/21 Morgan Stanley Bayer price target lowered to EUR 66 from EUR 68 at Morgan Stanley 02/26/21 Credit Suisse Bayer price target raised to EUR 56 from EUR 55 at Credit Suisse 02/10/21 Barclays Bayer price target raised to EUR 55 from EUR 50 at Barclays BAYRY Bayer $0.00 / + (+0.00%) 02/25/21 Bayer sees 2021 core EPS approx. EUR5.60-EUR5.80 02/25/21 Bayer reports Q4 core EPS EUR1.32 vs. EUR1.44 last year 11/03/20 Bayer confirms FY20 targets, sees core EPS EUR6.70-EUR6.90 11/03/20 Bayer reports Q3 core EPS down 30.2% to EUR0.81 BAYRY Bayer $0.00 / + (+0.00%) 01/06/21 CureVac, Bayer reach alliance deal over COVID-19 vaccine, Reuters says 10/27/20 EPA clears use of Bayer's XtendiMax for five years, Reuters reports 10/11/20 Bayer, BASF fighting to keep weedkiller on U.S. farms, WSJ reports 09/15/20 Bayer resolves thousands of U.S. Roundup cases with trial lawyers, Reuters says BAYRY Bayer $0.00 / + (+0.00%) 01/07/21 Fly Intel: Pre-market Movers 09/30/20 Fly Intel: Wall Street's top stories for Wednesday 09/29/20 Fly Intel: Wall Street's top stories for Tuesday

Tuesday
On The Fly	Fly Intel: Wall Street's top stories for Tuesday » 16:48 03/02/21 03/02 16:48 03/02/21 16:48 TGT Target $173.40 / -12.72 (-6.83%) , KSS Kohl's $57.36 / +0.41 (+0.72%) , ZM Zoom Video $372.72 / -36.95 (-9.02%) , MRK Merck $72.85 / +0.48 (+0.66%) , JNJ Johnson & Johnson $159.01 / -0.32 (-0.20%) , ULTA Ulta Beauty $336.74 / -0.84 (-0.25%) , AAPL Apple $125.17 / -2.6 (-2.03%) , INTC Intel $61.22 / -1.66 (-2.64%) , PERI Perion Network $25.64 / +4.135 (+19.23%) , MORF Morphic $70.99 / -13.82 (-16.30%) , FGEN FibroGen $38.11 / -12.15 (-24.17%) , NVAX Novavax $205.89 / -34.44 (-14.33%) , RKT Rocket Companies $41.70 / +17.4 (+71.60%) Equity futures were… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ZM ULTA TGT RKT PERI NVAX MRK MORF KSS JNJ INTC FGEN AAPL ZM Zoom Video $372.72 / -36.95 (-9.02%) 03/01/21 Zoom Video jumps 8% to $444.10 after Q4 results, FY22 guidance beat estimates 03/01/21 Lumen announces launch of Zoom Phone 02/03/21 Zoom Video announces availability of Zoom Rooms innovations 01/26/21 User reports indicate Zoom Video experiencing issues, says DownDetector ULTA Ulta Beauty $336.74 / -0.84 (-0.25%) 02/26/21 Cronos Group to launch Happy Dance in Ulta Beauty 02/03/21 e.l.f. Beauty CEO: We're really pleased with the quarter 02/02/21 Ulta Beauty announces diversity and inclusion commitments TGT Target $173.40 / -12.72 (-6.83%) 03/02/21 Target plans to open five more sortation centers in 2021 03/02/21 Target plans to open 30-40 new stores each year 03/02/21 Target to open approx. 100 Ulta Beauty at Target shop-in-shops in 2021 03/02/21 Target plans to invest $4B annually during next several years RKT Rocket Companies $41.70 / +17.4 (+71.60%) 03/02/21 Rocket Companies soars as short interest gets highlighted 03/02/21 Rocket resumes trading after volatility halt, shares up 57% to $38.07 03/02/21 Rocket Companies trading resumes 03/02/21 Rocket Companies trading halted, volatility trading pause PERI Perion Network $25.64 / +4.135 (+19.23%) 01/19/21 Perion Network trading halted, news pending 12/07/20 Perion Network jumps 8% to $8.37 after raising Q4, FY20 guidance 11/02/20 Perion Network, Microsoft renew strategic partnership for four more years NVAX Novavax $205.89 / -34.44 (-14.33%) 02/26/21 Novavax, Takeda finalize license agreement for COVID-19 vaccine in Japan 02/24/21 Takeda provides update on Novavax, Moderna COVID-19 vaccine candidates in Japan 02/22/21 House committee posts remarks from Pfizer, Moderna, J&J execs ahead of testimony 02/22/21 Novavax completes enrollment of PREVENT-19 Phase 3 trial MRK Merck $72.85 / +0.48 (+0.66%) 03/02/21 Merck to help produce Johnson & Johnson COVID-19 vaccine 03/01/21 Merck announces voluntary withdrawal for KEYTRUDA in SCLC 03/01/21 Merck: FDA accepts gefapixant New Drug Application for review 02/25/21 Merck to acquire Pandion Therapeutics for $60 per share in cash MORF Morphic $70.99 / -13.82 (-16.30%) 03/01/21 Morphic Holding Inc trading resumes 03/01/21 Morphic Holding Inc trading halted, volatility trading pause 03/01/21 Morphic Holding reports interim results from Phase 1 trial of MORF-057 01/05/21 Morphic Therapeutic expands R&D collaboration with Janssen KSS Kohl's $57.36 / +0.41 (+0.72%) 03/02/21 Kohl's planning $200M-$300M in share repurchases in 2021 03/02/21 Kohl's plans to refresh approximately 675 stores over the next two years 03/02/21 Kohl's 'optimistic that brighter days are ahead' 03/02/21 Kohl's 'confident' in ability to expand operating margin to 7%-8% by 2023 JNJ Johnson & Johnson $159.01 / -0.32 (-0.20%) 02/28/21 Fly Intel: Top five weekend stock stories 02/28/21 CDC Advisory Committee recommends J&J single-shot COVID vaccine for adults 18+ 02/27/21 Johnson & Johnson Covid vaccine granted emergency approval from FDA INTC Intel $61.22 / -1.66 (-2.64%) 02/25/21 Mobileye, Transdev ATS, Lohr Group to develop and deploy autonomous shuttles 02/22/21 Intrusion appoints Gary Davis as CMO 02/16/21 Greenlight Capital buys FuboTV and Danimer Scientific, exits Intel 02/01/21 Vuzix reports dividend settlement pact, sale of stake by Intel FGEN FibroGen $38.11 / -12.15 (-24.17%) 03/01/21 FibroGen, AstraZeneca report FDA to hold AdCom meeting to review roxadustat NDA 12/22/20 FibroGen doses first patient in ZEPHYRUS-2 Phase 3 study of pamrevlumab 12/19/20 AstraZeneca updates on U.S. regulatory review of roxadustat 12/18/20 FibroGen says FDA extends review period for roxadustat NDA AAPL Apple $125.17 / -2.6 (-2.03%) 02/25/21 Target announces enhanced Apple shopping experience for customers 02/19/21 Luminar, Velodyne Lidar move up after Bloomberg says Apple looking at LiDAR 02/19/21 Energous jumps 53% on Bloomberg report that Apple is working on battery pack TGT KSS ZM MRK JNJ ULTA AAPL INTC PERI MORF FGEN NVAX RKT TGT Target $173.40 / -12.72 (-6.83%) 03/03/21 Jefferies Target price target lowered to $188 from $205 at Jefferies 03/03/21 DA Davidson Target price target lowered to $210 from $229 at DA Davidson 03/03/21 Stifel Stifel buyers on weakness in Target, sees pullback as attractive entry point 03/02/21 Baird Target price target lowered to $200 from $220 at Baird KSS Kohl's $57.36 / +0.41 (+0.72%) 03/03/21 Credit Suisse Kohl's price target raised to $58 from $30 at Credit Suisse 03/03/21 Cowen Kohl's price target raised to $67 from $65 at Cowen 03/03/21 Citi Kohl's price target raised to $67 from $56 at Citi 02/18/21 Morgan Stanley Kohl's price target raised to $40 from $27 at Morgan Stanley ZM Zoom Video $372.72 / -36.95 (-9.02%) 03/02/21 Fly Intel: Top five analyst upgrades 03/02/21 Morgan Stanley Zoom Video price target raised to $420 from $390 at Morgan Stanley 03/02/21 Piper Sandler Zoom Video upgraded to Overweight from Neutral at Piper Sandler 01/26/21 MKM Partners Fiverr downgraded to Sell from Neutral at MKM Partners MRK Merck $72.85 / +0.48 (+0.66%) 02/25/21 SVB Leerink Pandion Therapeutics downgraded to Market Perform from Outperform at SVB Leerink 02/25/21 Morgan Stanley Pandion downgraded to Equal Weight from Overweight at Morgan Stanley 02/17/21 William Blair William Blair 'highly encouraged' by Nektar's collaborations with Merk, SFJ 01/21/21 Wedbush Scholar Rock price target raised to $66 from $47 at Wedbush JNJ Johnson & Johnson $159.01 / -0.32 (-0.20%) 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' ULTA Ulta Beauty $336.74 / -0.84 (-0.25%) 03/01/21 UBS Ulta Beauty price target raised to $365 from $335 at UBS 02/17/21 Oppenheimer Ulta Beauty price target raised to $360 from $305 at Oppenheimer 01/27/21 Citi Ulta Beauty downgraded to Neutral from Buy at Citi 01/21/21 Wells Fargo Ulta Beauty price target raised to $330 from $320 at Wells Fargo AAPL Apple $125.17 / -2.6 (-2.03%) 03/01/21 Wedbush Asia checks bullish for Apple iPhone 12 builds, says Wedbush 03/01/21 JPMorgan Broadcom won new new wireless charging chipset in iPhone 13, says JPMorgan 02/25/21 JPMorgan JPMorgan 'tweaks' EPS estimate for Apple after cut to iPhone forecasts 02/24/21 Piper Sandler Piper sees Apple developing 'full-blown' branded electric vehicle INTC Intel $61.22 / -1.66 (-2.64%) 02/25/21 Mizuho Intel price target raised to $70 from $68 at Mizuho 02/12/21 Lynx Intel price target raised to $75 from $70 at Lynx 02/08/21 Loop Capital MaxLinear upgraded to Buy from Hold at Loop Capital 02/01/21 Fly Intel: Top five analyst downgrades PERI Perion Network $25.64 / +4.135 (+19.23%) 02/10/21 Lake Street Perion Network price target raised to $30 from $18 at Lake Street 02/10/21 Roth Capital Perion Network price target raised to $30 from $16 at Roth Capital 01/04/21 Lake Street Perion Network price target raised to $18 from $12 at Lake Street 12/31/20 Sidoti Perion Network price target raised to $14 from $12 at Sidoti MORF Morphic $70.99 / -13.82 (-16.30%) 03/01/21 Wells Fargo Morphic Holding price target raised to $103 from $40 at Wells Fargo 02/02/21 RBC Capital Morphic Holding price target raised to $50 from $35 at RBC Capital 10/26/20 RBC Capital Morphic Holding initiated with an Outperform at RBC Capital 08/11/20 BMO Capital Morphic Holding price target raised to $37 from $30 at BMO Capital FGEN FibroGen $38.11 / -12.15 (-24.17%) 03/02/21 Fly Intel: Top five analyst downgrades 03/02/21 Jefferies FibroGen downgraded to Hold at Jefferies on increased risk for roxadustat 03/02/21 Citi FibroGen selloff on FDA panel a buying opportunity, says Citi 03/02/21 Jefferies FibroGen downgraded to Hold from Buy at Jefferies NVAX Novavax $205.89 / -34.44 (-14.33%) 02/23/21 B. Riley Securities B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance 02/22/21 Cantor Fitzgerald Cantor says PREVENT-19 gives Novavax potential for differentiated analyses 02/22/21 B. Riley Securities B. Riley reiterates Buy rating on Novavax as PREVENT-19 enrollment wraps up 02/18/21 B. Riley Securities Novavax price target raised to $397 from $334 at B. Riley Securities RKT Rocket Companies $41.70 / +17.4 (+71.60%) 03/03/21 Zelman Rocket Companies downgraded to Hold from Buy at Zelman 03/02/21 RBC Capital Rocket Companies downgraded to Sector Perform from Outperform at RBC Capital 03/02/21 Wells Fargo Wells says Rocket Companies Q4 results 'not good enough to support' today's move 01/19/21 JPMorgan JPMorgan double downgrades Rocket on more cautious mortgage stance ZM ULTA TGT RKT PERI NVAX MRK MORF KSS JNJ INTC FGEN AAPL ZM Zoom Video $372.72 / -36.95 (-9.02%) 03/01/21 Zoom Video sees FY22 EPS $3.59-$3.65, consensus $2.96 03/01/21 Zoom Video sees Q1 EPS 95c-97c, consensus 72c 03/01/21 Zoom Video reports Q4 EPS $1.22, consensus 79c 03/01/21 Notable companies reporting after market close ULTA Ulta Beauty $336.74 / -0.84 (-0.25%) 12/03/20 Ulta Beauty reports Q3 EPS $1.64, consensus $1.49 12/03/20 Notable companies reporting after market close TGT Target $173.40 / -12.72 (-6.83%) 03/02/21 Target reports Q4 adjusted EPS $2.67, consensus $2.54 03/01/21 Notable companies reporting before tomorrow's open 11/18/20 Target reports Q3 total revenue $22.63B, consensus $20.93B RKT Rocket Companies $41.70 / +17.4 (+71.60%) 02/25/21 Rocket Companies reports Q4 adjusted EPS $1.14, consensus 87c 02/25/21 Notable companies reporting after market close 11/10/20 Rocket Companies sees Q4 closed loan volume $88B-93B 11/10/20 Rocket Companies reports Q3 EPS 54c, consensus $1.09 PERI Perion Network $25.64 / +4.135 (+19.23%) 03/02/21 Perion Network raises FY21 revenue view to $370M-$380M from $350-$370 02/09/21 Perion Network sees FY21 revenue $350M-$370M, consensus $353.3M 02/09/21 Perion Network reports Q4 adjusted EPS 45c, consensus 18c 01/19/21 Perion Network sees Q4 EPS 35c-36, consensus 23c NVAX Novavax $205.89 / -34.44 (-14.33%) 03/01/21 Novavax reports Q4 EPS ($2.70), consensus ($1.49) 11/09/20 Novavax reports Q3 EPS ($3.21), may not compare to consensus $1.73 MRK Merck $72.85 / +0.48 (+0.66%) 02/04/21 Merck sees FY21 adjusted EPS $6.48-$6.68, consensus $6.41 02/04/21 Merck reports Q4 adjusted EPS $1.32, consensus $1.38 02/03/21 Notable companies reporting before tomorrow's open MORF Morphic $70.99 / -13.82 (-16.30%) 03/01/21 Morphic Holding reports 2020 EPS ($1.47), consensus ($1.41) 11/09/20 Morphic Holding reports Q3 EPS 17c, consensus (48c) KSS Kohl's $57.36 / +0.41 (+0.72%) 03/02/21 Kohl's sees FY21 EPS $2.45-$2.95, consensus ($2.43) 02/04/21 Kohl's reports preliminary Q4 EPS $1.00-$1.05, consensus 70c JNJ Johnson & Johnson $159.01 / -0.32 (-0.20%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open INTC Intel $61.22 / -1.66 (-2.64%) 01/21/21 Intel sees Q1 EPS $1.10, consensus 93c 01/21/21 Intel reports Q4 EPS $1.52, consensus $1.10 01/21/21 Notable companies reporting after market close 01/13/21 Intel sees Q4 revenue and EPS to exceed prior guidance FGEN FibroGen $38.11 / -12.15 (-24.17%) 03/01/21 FibroGen reports Q4 EPS (64c), consensus (24c) 11/05/20 FibroGen reports Q3 EPS 35c, consensus (80c) AAPL Apple $125.17 / -2.6 (-2.03%) 01/27/21 Apple reports Q1 EPS $1.70, consensus $1.41 01/27/21 Notable companies reporting after market close 10/29/20 Apple says Q4 results were ahead of expectations 10/29/20 Apple reports Q4 Services revenue $14.55B vs. $12.51B last year 03 Mar 20 Jan 13 Jan 06 Aug ZM ULTA TGT RKT NVAX MRK KSS JNJ INTC AAPL ZM Zoom Video $372.72 / -36.95 (-9.02%) 12/23/20 Zoom Video developing web email service, Information reports 11/13/20 NYC mayor warns parents to plan for school shutdown, Bloomberg reports 11/10/20 Microsoft wants to demolish video-conferencing competition, BI reports 10/14/20 Zoom's Yuan says won't develop chat service to rival Slack, Bloomberg reports ULTA Ulta Beauty $336.74 / -0.84 (-0.25%) 10/12/20 Ulta Beauty speculated as possible activist target by Activist Insights TGT Target $173.40 / -12.72 (-6.83%) 02/26/21 Costco to hike minimum hourly wage to $16 an hour, WSJ reports 12/06/20 Chick-fil-A sues Tyson, others for poultry price-fixing, Bloomberg says 11/14/20 Targe booming during pandemic, stock still undervalued, Barron's says 10/24/20 Sprouts Farmers ready for rebound, Barron's says RKT Rocket Companies $41.70 / +17.4 (+71.60%) 10/01/20 Realtor.com announces new partnership with Rocket Mortgage, Inman reports NVAX Novavax $205.89 / -34.44 (-14.33%) 02/11/21 EU official tells Reuters Novavax vaccine deal is close 01/29/21 Novavax expects to make 150M vaccine doses per month by May/June, Reuters says 01/11/21 EU close to 200M dose deal with Novavax, Moderna talks ongoing, Reuters reports 11/04/20 Novovax, Pfizer secure vaccine agreements with Australia, SMH reports MRK Merck $72.85 / +0.48 (+0.66%) 03/02/21 Merck to help produce J&J Covid vaccine, Washington Post reports 02/10/21 Merck in talks to produce authorized COVID-19 vaccines, WSJ says 02/03/21 Records show Merck's Propecia has trail of suicide reports, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says KSS Kohl's $57.36 / +0.41 (+0.72%) 02/22/21 Kohl's 'rejects' activist investor group attempt in statement to CNBC 02/21/21 Nine directors nominated to Kohl's board by activist investors, WSJ reports 09/21/20 Walmart to launch private label for men's and women's clothing, CNBC reports JNJ Johnson & Johnson $159.01 / -0.32 (-0.20%) 03/02/21 IPG Mediabrands planning event focused on Black-owned media firms, AdAge says 03/02/21 Johnson & Johnson Covid-19 vaccine shipments begin rollout, WSJ reports 02/26/21 FDA panel says J&J COVID-19 vaccine benefits outweigh risks, CNBC says INTC Intel $61.22 / -1.66 (-2.64%) 03/02/21 Jury tells Intel to pay $2.18B after losing patent trial, Bloomberg says 02/12/21 Tech companies seek intervention in Nvidia acquisition of Arm, Bloomberg says 02/11/21 Biden administration called on by chip industry to fund factories, Reuters says AAPL Apple $125.17 / -2.6 (-2.03%) 03/02/21 New Apple Card users get 6% Daily Cash on Apple purchases, 9to5Mac says 03/01/21 New EU 'Right to Repair' rules require goods to be repairable, Independent says 03/01/21 All Apple stores in U.S. open for first time since pandemic, CNBC reports 02/24/21 Biden to address chip shortages with executive action, WSJ reports ZM ULTA TGT RKT PERI MRK MORF KSS JNJ INTC FGEN AAPL ZM Zoom Video $372.72 / -36.95 (-9.02%) 03/02/21 Piper Sandler upgrades Zoom Video after 'very strong end' to FY21 03/02/21 Zoom Video, TripAdvisor upgrades among today's top calls ULTA Ulta Beauty $336.74 / -0.84 (-0.25%) 12/04/20 Fly Intel: Wall Street's top stories for Friday 12/04/20 Fly Intel: Wall Street's top stories at midday 12/04/20 Fly Intel: Pre-market Movers TGT Target $173.40 / -12.72 (-6.83%) 03/02/21 Fly Intel: Wall Street's top stories for Tuesday 03/02/21 Fly Intel: Wall Street's top stories at midday 03/01/21 Fly Intel: What to watch in Target's earnings report 02/26/21 Fly Intel: Wall Street's top stories at midday RKT Rocket Companies $41.70 / +17.4 (+71.60%) 02/25/21 Fly Intel: After-Hours Movers 11/10/20 Fly Intel: After-Hours Movers 09/02/20 Fly Intel: After-Hours Movers PERI Perion Network $25.64 / +4.135 (+19.23%) 01/19/21 Fly Intel: After-Hours Movers 12/07/20 Fly Intel: Wall Street's top stories for Monday MRK Merck $72.85 / +0.48 (+0.66%) 02/25/21 Fly Intel: Wall Street's top stories for Thursday 02/25/21 Fly Intel: Wall Street's top stories at midday MORF Morphic $70.99 / -13.82 (-16.30%) 03/01/21 Fly Intel: After-Hours Movers KSS Kohl's $57.36 / +0.41 (+0.72%) 03/02/21 Fly Intel: Pre-market Movers 02/22/21 Fly Intel: Wall Street's top stories for Monday JNJ Johnson & Johnson $159.01 / -0.32 (-0.20%) 03/01/21 Fly Intel: Wall Street's top stories for Monday 03/01/21 Fly Intel: Wall Street's top stories at midday INTC Intel $61.22 / -1.66 (-2.64%) 02/09/21 Fly Intel: Wall Street's top stories for Tuesday 02/01/21 Lowe's downgrade, Tesla price hike among today's top calls on Wall Street FGEN FibroGen $38.11 / -12.15 (-24.17%) 12/21/20 Fly Intel: Wall Street's top stories for Monday AAPL Apple $125.17 / -2.6 (-2.03%) 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/25/21 Analysts cut Verizon, AT&T ratings after companies spend big in FCC auction 02/20/21 Charged: Analyst sees Apple announcing EV partnership in 2021 03/05/21 Medical Technology 03/08/21 Biopharmaceuticals 03/17/21 Technology 04/09/21 Pharma/Biopharma 03/02/21 41st Annual Healthcare Virtual Conference 03/02/21 42nd Annual Institutional Investors Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference 03/02/21 Target - TGT 03/02/21 Kohl's - KSS 03/11/21 Ulta Beauty - ULTA 04/20/21 Johnson & Johnson - JNJ 04/22/21 Intel - INTC 04/29/21 Merck - MRK 03/20/21 PDUFA Date for Roxadustat--Extended Date 03/29/21 PDUFA Date for KEYTRUDA 04/13/21 PDUFA Date for Keytrude w/Chemotherapy 07/18/21 PDUFA Date for V114 11/28/21 PDUFA Date for KEYTRUDA (Phase 3 KEYNOTE-355 Trial) 12/21/21 PDUFA Date for Gefapixant 03/02/21 Target Corporation 03/08/21 Perion Network Ltd. ZM ULTA TGT RKT NVAX MRK KSS JNJ INTC FGEN AAPL ZM Zoom Video $372.72 / -36.95 (-9.02%) 03/01/21 Zoom Video Communications options imply 15.8% move in share price post-earnings 02/05/21 Zoom Video Communications call volume above normal and directionally bullish 01/15/21 Zoom Video Communications call volume above normal and directionally bullish 01/12/21 Zoom Video Communications call volume above normal and directionally bullish ULTA Ulta Beauty $336.74 / -0.84 (-0.25%) 12/03/20 Ulta Beauty options imply 10.1% move in share price post-earnings 11/10/20 Early notable gainers among liquid option names on November 10th 11/10/20 Unusually active option classes on open November 10th TGT Target $173.40 / -12.72 (-6.83%) 03/02/21 Early notable gainers among liquid option names on March 2nd 03/02/21 Unusually active option classes on open March 2nd 11/19/20 Early notable gainers among liquid option names on November 19th 11/17/20 Unusually active option classes on open November 17th RKT Rocket Companies $41.70 / +17.4 (+71.60%) 03/02/21 Callapalozza in Rocket Mortage echoes Gamestop squeeze 03/01/21 Rocket Companies call volume above normal and directionally bullish NVAX Novavax $205.89 / -34.44 (-14.33%) 03/01/21 Novavax options imply 15.7% move in share price post-earnings 02/22/21 Million dollar long-shot call spread buyer in Noravax will cross earnings 11/27/20 Unusually active option classes on open November 27th 11/13/20 Novavax call volume above normal and directionally bullish MRK Merck $72.85 / +0.48 (+0.66%) 02/17/21 Merck call volume above normal and directionally bullish 12/23/20 Merck call volume above normal and directionally bullish 10/20/20 Merck put volume heavy and directionally bearish KSS Kohl's $57.36 / +0.41 (+0.72%) 01/11/21 Early notable gainers among liquid option names on January 11th 12/30/20 Early notable gainers among liquid option names on December 30th 12/18/20 Early notable gainers among liquid option names on December 18th 12/11/20 Kohl's put volume heavy and directionally bearish JNJ Johnson & Johnson $159.01 / -0.32 (-0.20%) 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th INTC Intel $61.22 / -1.66 (-2.64%) 02/11/21 Intel call volume above normal and directionally bullish 01/22/21 Notable open interest changes for January 22nd 01/21/21 Intel options imply 9.0% move in share price post-earnings 01/13/21 Early notable gainers among liquid option names on January 13th FGEN FibroGen $38.11 / -12.15 (-24.17%) 10/12/20 Unusually active option classes on open October 12th AAPL Apple $125.17 / -2.6 (-2.03%) 03/02/21 Notable open interest changes for March 2nd 03/02/21 Apple call buyer realizes 91% same-day gains 03/01/21 Notable open interest changes for March 1st 02/26/21 Notable open interest changes for February 26th
Hot Stocks	Merck to help produce Johnson & Johnson COVID-19 vaccine » 16:32 03/02/21 03/02 16:32 03/02/21 16:32 MRK Merck $72.85 / +0.48 (+0.66%) , JNJ Johnson & Johnson $159.01 / -0.32 (-0.20%) Merck (MRK) announced it… Merck (MRK) announced it has entered into multiple agreements to support efforts to expand manufacturing capacity and supply of SARS-CoV-2/COVID-19 medicines and vaccines. The Biomedical Advanced Research and Development Authority, BARDA, a division of the Office of the Assistant Secretary for Preparedness and Response, ASPR, within the U.S. Department of Health and Human Services, HHS, will provide Merck with funding of up to $268.8M to adapt and make available a number of existing manufacturing facilities for the production of SARS-CoV-2/COVID-19 vaccines and medicines. Merck has also entered into agreements with Janssen Pharmaceuticals, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to support the manufacturing and supply of Johnson & Johnson's SARS-CoV-2/COVID-19 vaccine. Merck will use its facilities in the United States to produce drug substance, formulate and fill vials of Johnson & Johnson's vaccine. Under the terms of the BARDA agreement, Merck will adapt and make available some of the company's existing manufacturing sites to accelerate manufacturing efforts for SARS-CoV-2/COVID-19 vaccines and medicines. This funding is in addition to Merck's continued investment in its global vaccines manufacturing network as part of its planned capital investments of more than $20B from 2020 through the end of 2024. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MRK JNJ MRK Merck $72.85 / +0.48 (+0.66%) 03/01/21 Merck announces voluntary withdrawal for KEYTRUDA in SCLC 03/01/21 Merck: FDA accepts gefapixant New Drug Application for review 02/25/21 Merck to acquire Pandion Therapeutics for $60 per share in cash 02/25/21 Merck, Pandion Therapeutics deal has approx. total equity value of $1.85B JNJ Johnson & Johnson $159.01 / -0.32 (-0.20%) 02/28/21 Fly Intel: Top five weekend stock stories 02/28/21 CDC Advisory Committee recommends J&J single-shot COVID vaccine for adults 18+ 02/27/21 Johnson & Johnson Covid vaccine granted emergency approval from FDA 02/26/21 J&J confirms FDA panel recommends COVID-19 vaccine for EUA MRK JNJ MRK Merck $72.85 / +0.48 (+0.66%) 02/25/21 SVB Leerink Pandion Therapeutics downgraded to Market Perform from Outperform at SVB Leerink 02/25/21 Morgan Stanley Pandion downgraded to Equal Weight from Overweight at Morgan Stanley 02/17/21 William Blair William Blair 'highly encouraged' by Nektar's collaborations with Merk, SFJ 01/21/21 Wedbush Scholar Rock price target raised to $66 from $47 at Wedbush JNJ Johnson & Johnson $159.01 / -0.32 (-0.20%) 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' MRK JNJ MRK Merck $72.85 / +0.48 (+0.66%) 02/04/21 Merck sees FY21 adjusted EPS $6.48-$6.68, consensus $6.41 02/04/21 Merck reports Q4 adjusted EPS $1.32, consensus $1.38 02/03/21 Notable companies reporting before tomorrow's open JNJ Johnson & Johnson $159.01 / -0.32 (-0.20%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open MRK JNJ MRK Merck $72.85 / +0.48 (+0.66%) 03/02/21 Merck to help produce J&J Covid vaccine, Washington Post reports 02/10/21 Merck in talks to produce authorized COVID-19 vaccines, WSJ says 02/03/21 Records show Merck's Propecia has trail of suicide reports, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says JNJ Johnson & Johnson $159.01 / -0.32 (-0.20%) 03/02/21 IPG Mediabrands planning event focused on Black-owned media firms, AdAge says 03/02/21 Johnson & Johnson Covid-19 vaccine shipments begin rollout, WSJ reports 02/26/21 FDA panel says J&J COVID-19 vaccine benefits outweigh risks, CNBC says MRK JNJ MRK Merck $72.85 / +0.48 (+0.66%) 03/02/21 Fly Intel: Wall Street's top stories at midday 02/25/21 Fly Intel: Wall Street's top stories for Thursday 02/25/21 Fly Intel: Wall Street's top stories at midday 02/25/21 Fly Intel: Pre-market Movers JNJ Johnson & Johnson $159.01 / -0.32 (-0.20%) 03/01/21 Fly Intel: Wall Street's top stories for Monday 03/01/21 Fly Intel: Wall Street's top stories at midday 03/01/21 Fly Intel: Pre-market Movers 03/05/21 Medical Technology 03/08/21 Biopharmaceuticals 04/09/21 Pharma/Biopharma 03/02/21 41st Annual Healthcare Virtual Conference 03/02/21 42nd Annual Institutional Investors Virtual Conference 04/20/21 Johnson & Johnson - JNJ 04/29/21 Merck - MRK 03/29/21 PDUFA Date for KEYTRUDA 04/13/21 PDUFA Date for Keytrude w/Chemotherapy 07/18/21 PDUFA Date for V114 11/28/21 PDUFA Date for KEYTRUDA (Phase 3 KEYNOTE-355 Trial) 12/21/21 PDUFA Date for Gefapixant MRK JNJ MRK Merck $72.85 / +0.48 (+0.66%) 03/02/21 Unusually active option classes on open March 2nd 02/17/21 Merck call volume above normal and directionally bullish 12/23/20 Merck call volume above normal and directionally bullish 10/20/20 Merck put volume heavy and directionally bearish JNJ Johnson & Johnson $159.01 / -0.32 (-0.20%) 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th
On The Fly	Fly Intel: Wall Street's top stories at midday » 12:25 03/02/21 03/02 12:25 03/02/21 12:25 TGT Target $177.29 / -8.83 (-4.74%) , KSS Kohl's $58.35 / +1.4 (+2.46%) , JNJ Johnson & Johnson $159.38 / +0.05 (+0.03%) , MRK Merck $73.20 / +0.83 (+1.15%) , ZM Zoom Video $401.54 / -8.125 (-1.98%) , PERI Perion Network $27.00 / +5.495 (+25.55%) , AMRS Amyris $20.46 / +4.84 (+30.99%) , MORF Morphic $73.25 / -11.56 (-13.63%) , FGEN FibroGen $35.50 / -14.76 (-29.37%) , NVAX Novavax $201.33 / -39 (-16.23%) Equity futures were… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ZM TGT PERI NVAX MRK MORF KSS JNJ FGEN AMRS ZM Zoom Video $401.54 / -8.125 (-1.98%) 03/01/21 Zoom Video jumps 8% to $444.10 after Q4 results, FY22 guidance beat estimates 03/01/21 Lumen announces launch of Zoom Phone 02/03/21 Zoom Video announces availability of Zoom Rooms innovations 01/26/21 User reports indicate Zoom Video experiencing issues, says DownDetector TGT Target $177.29 / -8.83 (-4.74%) 03/02/21 Target 'off to a strong start' in February, with comps up 20% 03/02/21 Target says testing new sortation center to expedite online orders 03/02/21 Target says 'our business model is working as intended' 03/02/21 Target not providing FY21 guidance 'in the face of continued uncertainty' PERI Perion Network $27.00 / +5.495 (+25.55%) 01/19/21 Perion Network trading halted, news pending 12/07/20 Perion Network jumps 8% to $8.37 after raising Q4, FY20 guidance 11/02/20 Perion Network, Microsoft renew strategic partnership for four more years NVAX Novavax $201.33 / -39 (-16.23%) 02/26/21 Novavax, Takeda finalize license agreement for COVID-19 vaccine in Japan 02/24/21 Takeda provides update on Novavax, Moderna COVID-19 vaccine candidates in Japan 02/22/21 House committee posts remarks from Pfizer, Moderna, J&J execs ahead of testimony 02/22/21 Novavax completes enrollment of PREVENT-19 Phase 3 trial MRK Merck $73.20 / +0.83 (+1.15%) 03/01/21 Merck announces voluntary withdrawal for KEYTRUDA in SCLC 03/01/21 Merck: FDA accepts gefapixant New Drug Application for review 02/25/21 Merck to acquire Pandion Therapeutics for $60 per share in cash 02/25/21 Merck, Pandion Therapeutics deal has approx. total equity value of $1.85B MORF Morphic $73.25 / -11.56 (-13.63%) 03/01/21 Morphic Holding Inc trading resumes 03/01/21 Morphic Holding Inc trading halted, volatility trading pause 03/01/21 Morphic Holding reports interim results from Phase 1 trial of MORF-057 01/05/21 Morphic Therapeutic expands R&D collaboration with Janssen KSS Kohl's $58.35 / +1.4 (+2.46%) 03/02/21 Kohl's planning $200M-$300M in share repurchases in 2021 03/02/21 Kohl's plans to refresh approximately 675 stores over the next two years 03/02/21 Kohl's 'optimistic that brighter days are ahead' 03/02/21 Kohl's 'confident' in ability to expand operating margin to 7%-8% by 2023 JNJ Johnson & Johnson $159.38 / +0.05 (+0.03%) 02/28/21 Fly Intel: Top five weekend stock stories 02/28/21 CDC Advisory Committee recommends J&J single-shot COVID vaccine for adults 18+ 02/27/21 Johnson & Johnson Covid vaccine granted emergency approval from FDA 02/26/21 J&J confirms FDA panel recommends COVID-19 vaccine for EUA FGEN FibroGen $35.50 / -14.76 (-29.37%) 03/01/21 FibroGen, AstraZeneca report FDA to hold AdCom meeting to review roxadustat NDA 12/22/20 FibroGen doses first patient in ZEPHYRUS-2 Phase 3 study of pamrevlumab 12/19/20 AstraZeneca updates on U.S. regulatory review of roxadustat 12/18/20 FibroGen says FDA extends review period for roxadustat NDA AMRS Amyris $20.46 / +4.84 (+30.99%) 03/01/21 Amyris to acquire Costa Brazil brand, terms not disclosed 02/24/21 Amyris launches Pipette clean baby care brand in Target 02/22/21 Amyris announces pre-clinical results for COVID RNA vaccine platform 02/02/21 Amyris announces results from clinical study of clean topical formulation TGT KSS JNJ MRK ZM PERI AMRS MORF FGEN NVAX TGT Target $177.29 / -8.83 (-4.74%) 02/09/21 Jefferies Dollar General well-positioned to mitigate minimum wage headwind, says Jefferies 02/08/21 Fly Intel: Top five analyst upgrades 02/08/21 Stifel Target upgraded to Buy from Hold at Stifel 01/14/21 DA Davidson Target price target raised to $229 from $208 at DA Davidson KSS Kohl's $58.35 / +1.4 (+2.46%) 02/18/21 Morgan Stanley Kohl's price target raised to $40 from $27 at Morgan Stanley 02/05/21 Baird Kohl's price target raised to $58 from $48 at Baird 02/05/21 Deutsche Bank Kohl's price target raised to $55 from $51 at Deutsche Bank 02/03/21 Fly Intel: Top five analyst upgrades JNJ Johnson & Johnson $159.38 / +0.05 (+0.03%) 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' MRK Merck $73.20 / +0.83 (+1.15%) 02/25/21 SVB Leerink Pandion Therapeutics downgraded to Market Perform from Outperform at SVB Leerink 02/25/21 Morgan Stanley Pandion downgraded to Equal Weight from Overweight at Morgan Stanley 02/17/21 William Blair William Blair 'highly encouraged' by Nektar's collaborations with Merk, SFJ 01/21/21 Wedbush Scholar Rock price target raised to $66 from $47 at Wedbush ZM Zoom Video $401.54 / -8.125 (-1.98%) 03/02/21 Fly Intel: Top five analyst upgrades 03/02/21 Morgan Stanley Zoom Video price target raised to $420 from $390 at Morgan Stanley 03/02/21 Piper Sandler Zoom Video upgraded to Overweight from Neutral at Piper Sandler 01/26/21 MKM Partners Fiverr downgraded to Sell from Neutral at MKM Partners PERI Perion Network $27.00 / +5.495 (+25.55%) 02/10/21 Lake Street Perion Network price target raised to $30 from $18 at Lake Street 02/10/21 Roth Capital Perion Network price target raised to $30 from $16 at Roth Capital 01/04/21 Lake Street Perion Network price target raised to $18 from $12 at Lake Street 12/31/20 Sidoti Perion Network price target raised to $14 from $12 at Sidoti AMRS Amyris $20.46 / +4.84 (+30.99%) 02/26/21 Fly Intel: Top five analyst initiations 02/26/21 Roth Capital Amyris initiated with a Buy at Roth Capital 01/06/21 Cowen Amyris upgraded to Outperform with $9 price target at Cowen 01/06/21 Cowen Amyris upgraded to Outperform from Market Perform at Cowen MORF Morphic $73.25 / -11.56 (-13.63%) 03/01/21 Wells Fargo Morphic Holding price target raised to $103 from $40 at Wells Fargo 02/02/21 RBC Capital Morphic Holding price target raised to $50 from $35 at RBC Capital 10/26/20 RBC Capital Morphic Holding initiated with an Outperform at RBC Capital 08/11/20 BMO Capital Morphic Holding price target raised to $37 from $30 at BMO Capital FGEN FibroGen $35.50 / -14.76 (-29.37%) 03/02/21 Fly Intel: Top five analyst downgrades 03/02/21 Jefferies FibroGen downgraded to Hold at Jefferies on increased risk for roxadustat 03/02/21 Citi FibroGen selloff on FDA panel a buying opportunity, says Citi 03/02/21 Jefferies FibroGen downgraded to Hold from Buy at Jefferies NVAX Novavax $201.33 / -39 (-16.23%) 02/23/21 B. Riley Securities B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance 02/22/21 Cantor Fitzgerald Cantor says PREVENT-19 gives Novavax potential for differentiated analyses 02/22/21 B. Riley Securities B. Riley reiterates Buy rating on Novavax as PREVENT-19 enrollment wraps up 02/18/21 B. Riley Securities Novavax price target raised to $397 from $334 at B. Riley Securities ZM TGT PERI NVAX MRK MORF KSS JNJ FGEN AMRS ZM Zoom Video $401.54 / -8.125 (-1.98%) 03/01/21 Zoom Video sees FY22 EPS $3.59-$3.65, consensus $2.96 03/01/21 Zoom Video sees Q1 EPS 95c-97c, consensus 72c 03/01/21 Zoom Video reports Q4 EPS $1.22, consensus 79c 03/01/21 Notable companies reporting after market close TGT Target $177.29 / -8.83 (-4.74%) 03/02/21 Target reports Q4 adjusted EPS $2.67, consensus $2.54 03/01/21 Notable companies reporting before tomorrow's open 11/18/20 Target reports Q3 total revenue $22.63B, consensus $20.93B PERI Perion Network $27.00 / +5.495 (+25.55%) 03/02/21 Perion Network raises FY21 revenue view to $370M-$380M from $350-$370 02/09/21 Perion Network sees FY21 revenue $350M-$370M, consensus $353.3M 02/09/21 Perion Network reports Q4 adjusted EPS 45c, consensus 18c 01/19/21 Perion Network sees Q4 EPS 35c-36, consensus 23c NVAX Novavax $201.33 / -39 (-16.23%) 03/01/21 Novavax reports Q4 EPS ($2.70), consensus ($1.49) 11/09/20 Novavax reports Q3 EPS ($3.21), may not compare to consensus $1.73 MRK Merck $73.20 / +0.83 (+1.15%) 02/04/21 Merck sees FY21 adjusted EPS $6.48-$6.68, consensus $6.41 02/04/21 Merck reports Q4 adjusted EPS $1.32, consensus $1.38 02/03/21 Notable companies reporting before tomorrow's open MORF Morphic $73.25 / -11.56 (-13.63%) 03/01/21 Morphic Holding reports 2020 EPS ($1.47), consensus ($1.41) 11/09/20 Morphic Holding reports Q3 EPS 17c, consensus (48c) KSS Kohl's $58.35 / +1.4 (+2.46%) 03/02/21 Kohl's sees FY21 EPS $2.45-$2.95, consensus ($2.43) 02/04/21 Kohl's reports preliminary Q4 EPS $1.00-$1.05, consensus 70c JNJ Johnson & Johnson $159.38 / +0.05 (+0.03%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open FGEN FibroGen $35.50 / -14.76 (-29.37%) 03/01/21 FibroGen reports Q4 EPS (64c), consensus (24c) 11/05/20 FibroGen reports Q3 EPS 35c, consensus (80c) AMRS Amyris $20.46 / +4.84 (+30.99%) 03/02/21 Amyris sees FY21 revenue $400M, consensus $231.77M 03/02/21 Amyris reports Q4 adjusted EPS (3c), consensus (9c) 03 Mar 20 Jan 13 Jan ZM TGT NVAX MRK KSS JNJ ZM Zoom Video $401.54 / -8.125 (-1.98%) 12/23/20 Zoom Video developing web email service, Information reports 11/13/20 NYC mayor warns parents to plan for school shutdown, Bloomberg reports 11/10/20 Microsoft wants to demolish video-conferencing competition, BI reports 10/14/20 Zoom's Yuan says won't develop chat service to rival Slack, Bloomberg reports TGT Target $177.29 / -8.83 (-4.74%) 02/26/21 Costco to hike minimum hourly wage to $16 an hour, WSJ reports 12/06/20 Chick-fil-A sues Tyson, others for poultry price-fixing, Bloomberg says 11/14/20 Targe booming during pandemic, stock still undervalued, Barron's says 10/24/20 Sprouts Farmers ready for rebound, Barron's says NVAX Novavax $201.33 / -39 (-16.23%) 02/11/21 EU official tells Reuters Novavax vaccine deal is close 01/29/21 Novavax expects to make 150M vaccine doses per month by May/June, Reuters says 01/11/21 EU close to 200M dose deal with Novavax, Moderna talks ongoing, Reuters reports 11/04/20 Novovax, Pfizer secure vaccine agreements with Australia, SMH reports MRK Merck $73.20 / +0.83 (+1.15%) 02/10/21 Merck in talks to produce authorized COVID-19 vaccines, WSJ says 02/03/21 Records show Merck's Propecia has trail of suicide reports, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says KSS Kohl's $58.35 / +1.4 (+2.46%) 02/22/21 Kohl's 'rejects' activist investor group attempt in statement to CNBC 02/21/21 Nine directors nominated to Kohl's board by activist investors, WSJ reports 09/21/20 Walmart to launch private label for men's and women's clothing, CNBC reports JNJ Johnson & Johnson $159.38 / +0.05 (+0.03%) 03/02/21 Merck to help produce J&J Covid vaccine, Washington Post reports 03/02/21 Johnson & Johnson Covid-19 vaccine shipments begin rollout, WSJ reports 02/26/21 FDA panel says J&J COVID-19 vaccine benefits outweigh risks, CNBC says 02/26/21 FDA advisory panel to review J&J's Covid-19 vaccine Friday, WSJ reports ZM TGT PERI NVAX MRK KSS JNJ FGEN AMRS ZM Zoom Video $401.54 / -8.125 (-1.98%) 03/02/21 Zoom Video, TripAdvisor upgrades among today's top calls 03/01/21 Fly Intel: After-Hours Movers 03/01/21 Fly Intel: What to watch in Zoom Video earnings report TGT Target $177.29 / -8.83 (-4.74%) 03/01/21 Fly Intel: What to watch in Target's earnings report 02/26/21 Fly Intel: Wall Street's top stories at midday 02/08/21 Target, Estee Lauder upgrades among today's top calls on Wall Street 01/13/21 Fly Intel: Wall Street's top stories for Wednesday PERI Perion Network $27.00 / +5.495 (+25.55%) 01/19/21 Fly Intel: After-Hours Movers 12/07/20 Fly Intel: Wall Street's top stories for Monday 12/07/20 Fly Intel: Pre-market Movers 10/07/20 Fly Intel: Pre-market Movers NVAX Novavax $201.33 / -39 (-16.23%) 02/19/21 Fly Intel: Wall Street's top stories for Friday 02/19/21 Fly Intel: Wall Street's top stories at midday MRK Merck $73.20 / +0.83 (+1.15%) 02/25/21 Fly Intel: Wall Street's top stories for Thursday 02/25/21 Fly Intel: Wall Street's top stories at midday 02/25/21 Fly Intel: Pre-market Movers 02/04/21 Fly Intel: Wall Street's top stories for Thursday KSS Kohl's $58.35 / +1.4 (+2.46%) 03/02/21 Fly Intel: Pre-market Movers 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 02/22/21 Fly Intel: Pre-market Movers JNJ Johnson & Johnson $159.38 / +0.05 (+0.03%) 03/01/21 Fly Intel: Wall Street's top stories for Monday 03/01/21 Fly Intel: Wall Street's top stories at midday 03/01/21 Fly Intel: Pre-market Movers 02/24/21 Fly Intel: Wall Street's top stories for Wednesday FGEN FibroGen $35.50 / -14.76 (-29.37%) 12/21/20 Fly Intel: Wall Street's top stories for Monday 12/21/20 Fly Intel: Wall Street's top stories at midday 12/21/20 Fly Intel: Pre-market Movers AMRS Amyris $20.46 / +4.84 (+30.99%) 09/15/20 Fly Intel: Wall Street's top stories for Tuesday 09/15/20 Fly Intel: Wall Street's top stories at midday 09/11/20 Fly Intel: Wall Street's top stories for Friday 09/11/20 Fly Intel: Wall Street's top stories at midday 03/05/21 Medical Technology 03/08/21 Biopharmaceuticals 04/09/21 Pharma/Biopharma 03/02/21 41st Annual Healthcare Virtual Conference 03/02/21 42nd Annual Institutional Investors Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference 03/02/21 Target - TGT 03/02/21 Kohl's - KSS 03/02/21 Amyris - AMRS 04/20/21 Johnson & Johnson - JNJ 04/29/21 Merck - MRK 03/20/21 PDUFA Date for Roxadustat--Extended Date 03/29/21 PDUFA Date for KEYTRUDA 04/13/21 PDUFA Date for Keytrude w/Chemotherapy 07/18/21 PDUFA Date for V114 11/28/21 PDUFA Date for KEYTRUDA (Phase 3 KEYNOTE-355 Trial) 03/02/21 Target Corporation 03/08/21 Perion Network Ltd. ZM TGT NVAX MRK KSS JNJ FGEN AMRS ZM Zoom Video $401.54 / -8.125 (-1.98%) 03/01/21 Zoom Video Communications options imply 15.8% move in share price post-earnings 02/05/21 Zoom Video Communications call volume above normal and directionally bullish 01/15/21 Zoom Video Communications call volume above normal and directionally bullish 01/12/21 Zoom Video Communications call volume above normal and directionally bullish TGT Target $177.29 / -8.83 (-4.74%) 03/02/21 Early notable gainers among liquid option names on March 2nd 03/02/21 Unusually active option classes on open March 2nd 11/19/20 Early notable gainers among liquid option names on November 19th 11/17/20 Unusually active option classes on open November 17th NVAX Novavax $201.33 / -39 (-16.23%) 03/01/21 Novavax options imply 15.7% move in share price post-earnings 02/22/21 Million dollar long-shot call spread buyer in Noravax will cross earnings 11/27/20 Unusually active option classes on open November 27th 11/13/20 Novavax call volume above normal and directionally bullish MRK Merck $73.20 / +0.83 (+1.15%) 02/17/21 Merck call volume above normal and directionally bullish 12/23/20 Merck call volume above normal and directionally bullish 10/20/20 Merck put volume heavy and directionally bearish KSS Kohl's $58.35 / +1.4 (+2.46%) 01/11/21 Early notable gainers among liquid option names on January 11th 12/30/20 Early notable gainers among liquid option names on December 30th 12/18/20 Early notable gainers among liquid option names on December 18th 12/11/20 Kohl's put volume heavy and directionally bearish JNJ Johnson & Johnson $159.38 / +0.05 (+0.03%) 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th FGEN FibroGen $35.50 / -14.76 (-29.37%) 10/12/20 Unusually active option classes on open October 12th AMRS Amyris $20.46 / +4.84 (+30.99%) 01/04/21 Amyris call volume above normal and directionally bullish 12/30/20 Amyris call volume above normal and directionally bullish 12/28/20 Amyris call volume above normal and directionally bullish 12/24/20 Unusual call flow in option market yesterday

Upgrade	Atara Biotherapeutics upgraded to Buy at Citi following 35% pullback » 11:04 03/02/21 03/02 11:04 03/02/21 11:04 ATRA Atara Biotherapeutics $16.60 / -0.47 (-2.75%) , BAYRY Bayer $0.00 / + (+0.00%) As previously reported,… As previously reported, Citi analyst Yigal Nochomovitz upgraded Atara Biotherapeutics (ATRA) to Buy from Neutral with a $27 price target, noting that the stock has retreated by about 35% since early December when a collaboration with Bayer (BAYRY) for mesothelin CART programs ATA2271 and ATA3271 was announced. He now sees a more favorable risk/reward following the pullback, pointing to upcoming catalysts that include completing the rolling BLA submission for tab-cel in R/R EBV+ PTLD in Q3, the report of initial Phase 1 data for ATA2271 in Q4, and the communication of next steps for ATA188 in MS. ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly BAYRY ATRA BAYRY Bayer $0.00 / + (+0.00%) 02/24/21 Bayer to divest Environmental Science Professional business 02/17/21 Selecta, AskBio initiate first-in-human dose escalation study of ImmTOR 02/05/21 CureVac enters pact with UK Government to develop SARS-CoV-2 variant vaccine 02/03/21 Bayer announes $2B agreement to resolve future Roundup cases ATRA Atara Biotherapeutics $16.60 / -0.47 (-2.75%) 02/08/21 Atara Biotherapeutics to present tabelecleucel data at ASTCT meeting 01/04/21 Atara Biotherapeutics provides update on BLA submission for tab-cel 12/07/20 Atara presents evaluation of CAR T Cell Therapy ATA3219 at ASH 12/07/20 Bayer, Atara Biotherapeutics enter collaboration on CAR T-cell therapies ATRA BAYRY ATRA Atara Biotherapeutics $16.60 / -0.47 (-2.75%) 03/02/21 Citi Atara Biotherapeutics upgraded to Buy from Neutral at Citi 01/04/21 Roth Capital Roth keeps Buy rating on Atara Biotherapeutics after filing delay 01/04/21 Roth Capital Roth keeps Buy rating on Atara as initiation of BLA gets 'slightly' delayed 12/09/20 Citi Atara Biotherapeutics downgraded to Neutral from Buy at Citi BAYRY Bayer $0.00 / + (+0.00%) 03/01/21 Morgan Stanley Bayer price target lowered to EUR 66 from EUR 68 at Morgan Stanley 02/26/21 Credit Suisse Bayer price target raised to EUR 56 from EUR 55 at Credit Suisse 02/10/21 Barclays Bayer price target raised to EUR 55 from EUR 50 at Barclays 02/04/21 Citi opens positive 'Catalyst Watch' on Bayer BAYRY ATRA BAYRY Bayer $0.00 / + (+0.00%) 02/25/21 Bayer sees 2021 core EPS approx. EUR5.60-EUR5.80 02/25/21 Bayer reports Q4 core EPS EUR1.32 vs. EUR1.44 last year 11/03/20 Bayer confirms FY20 targets, sees core EPS EUR6.70-EUR6.90 11/03/20 Bayer reports Q3 core EPS down 30.2% to EUR0.81 ATRA Atara Biotherapeutics $16.60 / -0.47 (-2.75%) 03/01/21 Atara Biotherapeutics reports Q4 EPS (95c), consensus (74c) 11/12/20 Atara Biotherapeutics to present preclinical data on ATA3271 at SITC 2020 11/09/20 Atara Biotherapeutics reports Q3 EPS (92c), consensus ($1.09) 09 Dec 27 May BAYRY BAYRY Bayer $0.00 / + (+0.00%) 01/06/21 CureVac, Bayer reach alliance deal over COVID-19 vaccine, Reuters says 10/27/20 EPA clears use of Bayer's XtendiMax for five years, Reuters reports 10/11/20 Bayer, BASF fighting to keep weedkiller on U.S. farms, WSJ reports 09/15/20 Bayer resolves thousands of U.S. Roundup cases with trial lawyers, Reuters says BAYRY ATRA BAYRY Bayer $0.00 / + (+0.00%) 01/07/21 Fly Intel: Pre-market Movers 09/30/20 Fly Intel: Wall Street's top stories for Wednesday 09/29/20 Fly Intel: Wall Street's top stories for Tuesday ATRA Atara Biotherapeutics $16.60 / -0.47 (-2.75%) 12/07/20 Fly Intel: Pre-market Movers
Options	Unusually active option classes on open March 2nd » 09:40 03/02/21 03/02 09:40 03/02/21 09:40 RKT Rocket Companies $24.30 / + (+0.00%) , TGT Target $186.12 / + (+0.00%) , TXMD TherapeuticsMD $1.44 / + (+0.00%) , KOPN Kopin $9.14 / + (+0.00%) , SE Sea Limited $248.81 / + (+0.00%) , XL XL Fleet $14.87 / + (+0.00%) , SOS SOS Limited $6.68 / + (+0.00%) , MCD McDonald's $208.25 / + (+0.00%) , MRK Merck $72.37 / + (+0.00%) , BYND Beyond Meat $147.09 / -0.02 (-0.01%) Unusual total active… Unusual total active option classes on open include: Rocket Companies (RKT), Target (TGT), TherapeuticsMD (TXMD), Kopin (KOPN), Sea Limited (SE), XL Fleet (XL), SOS Limited (SOS), McDonald's (MCD), Merck (MRK), and Beyond Meat (BYND). ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options XL TXMD TGT SOS SE RKT MRK MCD KOPN BYND XL XL Fleet $14.87 / + (+0.00%) 02/25/21 XL Fleet partners with UBS Arena to deploy 1,000 EV stations 02/04/21 XL Fleet, Curbtender team to develop all-electric, plug-in hybrid refuse trucks 01/04/21 XL Fleet falls -14.5% 12/31/20 Exelon reports 5.3% passive stake in XL Fleet TXMD TherapeuticsMD $1.44 / + (+0.00%) 11/09/20 TherapeuticsMD begins process to divest vitaCare Prescription Services 09/21/20 TherapeuticsMD, Knight announces Health Canada approval of BIJUVA 09/09/20 TherapeuticsMD announces patent updates for Annovera TGT Target $186.12 / + (+0.00%) 03/02/21 Target says 'our business model is working as intended' 03/02/21 Target not providing FY21 guidance 'in the face of continued uncertainty' 03/02/21 Target reports Q4 digital comparable sales grew 118% 02/25/21 Target announces enhanced Apple shopping experience for customers SOS SOS Limited $6.68 / + (+0.00%) 03/01/21 SOS Limited rises 38.4% 03/01/21 SOS Limited rises 37.7% 03/01/21 SOS Limited rises 23.7% 03/01/21 SOS Limited responds to recent attack by short sellers SE Sea Limited $248.81 / + (+0.00%) 03/02/21 Sea Limited sees FY21 bookings for digital entertainment $4.3B-$4.5B 12/04/20 Sea Limited awarded license to operate digital full bank in Singapore 11/17/20 Sea Limited sees FY20 bookings for digital entertainment up 75.4% from last year RKT Rocket Companies $24.30 / + (+0.00%) 02/25/21 Rocket Companies announces special dividend of $1.11 per share 02/25/21 Rocket Companies sees Q1 closed loan volume $98B-$103B 11/11/20 Rocket Companies CEO: Our platform allows us to scale 11/10/20 Rocket Companies approves $1B share repurchase program MRK Merck $72.37 / + (+0.00%) 03/01/21 Merck announces voluntary withdrawal for KEYTRUDA in SCLC 03/01/21 Merck: FDA accepts gefapixant New Drug Application for review 02/25/21 Merck to acquire Pandion Therapeutics for $60 per share in cash 02/25/21 Merck, Pandion Therapeutics deal has approx. total equity value of $1.85B MCD McDonald's $208.25 / + (+0.00%) 03/02/21 McDonald's CEO vows to crack down on sexual harassment in the workplace 02/25/21 Beyond Meat says seeing 'great growth' in household penetration 02/25/21 Beyond Meat signs three-year agreement to be McPlant supplier for McDonald's 01/28/21 McDonald's sees FY21 system wide sales growth of low double digits KOPN Kopin $9.14 / + (+0.00%) 02/23/21 Kopin director Collins sells almost $2M in company shares 02/23/21 Kopin trading resumes 02/23/21 Kopin trading halted, volatility trading pause 02/02/21 Kopin, HMDmd in development pact for wearable display system for surgeons BYND Beyond Meat $147.09 / -0.02 (-0.01%) 02/25/21 Beyond Meat says currently in 'solid liquidity position' 02/25/21 Beyond Meat says proceeding with 'aggressive investment agenda' in 2021 02/25/21 Beyond Meat says 'not prepared to elaborate' on new partnerships RKT TGT TXMD KOPN SE XL SOS MCD MRK BYND RKT Rocket Companies $24.30 / + (+0.00%) 01/19/21 JPMorgan JPMorgan double downgrades Rocket on more cautious mortgage stance 01/19/21 JPMorgan Rocket Companies downgraded to Underweight from Overweight at JPMorgan 12/17/20 Keefe Bruyette Rocket Companies downgraded to Underperform at Keefe Bruyette 12/14/20 Fly Intel: Top five analyst initiations TGT Target $186.12 / + (+0.00%) 02/09/21 Jefferies Dollar General well-positioned to mitigate minimum wage headwind, says Jefferies 02/08/21 Fly Intel: Top five analyst upgrades 02/08/21 Stifel Target upgraded to Buy from Hold at Stifel 01/14/21 DA Davidson Target price target raised to $229 from $208 at DA Davidson TXMD TherapeuticsMD $1.44 / + (+0.00%) 01/28/21 H.C. Wainwright TherapeuticsMD price target lowered to $4 from $5 at H.C. Wainwright 08/07/20 Jefferies Jefferies downgrades 'show-me story' TherapeuticsMD to Underperform 08/07/20 Jefferies TherapeuticsMD downgraded to Underperform from Hold at Jefferies 05/19/20 Fly Intel: Top five analyst downgrades KOPN Kopin $9.14 / + (+0.00%) 01/11/21 H.C. Wainwright Kopin price target raised to $3.50 from $2 at H.C. Wainwright 08/25/20 Fly Intel: Top five analyst initiations 08/25/20 H.C. Wainwright Kopin initiated with a Buy at H.C. Wainwright 08/05/20 Ladenburg Kopin price target raised to $2.50 from $1.50 at Ladenburg SE Sea Limited $248.81 / + (+0.00%) 02/23/21 Cowen Sea Limited price target raised to $320 from $225 at Cowen 02/01/21 China Renaissance Sea Limited initiated with a Buy at China Renaissance 02/01/21 Morgan Stanley Sea Limited price target raised to $250 from $188 at Morgan Stanley 01/08/21 Stifel Sea Group secures banking license in Indonesia, says Stifel XL XL Fleet $14.87 / + (+0.00%) 01/29/21 Canaccord Canaccord sees XL Fleet going to $30 per share on 'first-mover' advantage 01/29/21 Canaccord XL Fleet initiated with a Buy at Canaccord 01/22/21 Fly Intel: Top five analyst initiations 01/22/21 BTIG XL Fleet initiated with a Buy at BTIG SOS SOS Limited $6.68 / + (+0.00%) MCD McDonald's $208.25 / + (+0.00%) 03/02/21 Citi Citi upgrades Beyond Meat to Buy with 'new-found enthusiasm' for long-term story 02/22/21 Wells Fargo Wells Fargo strategist upgrades Consumer Services sector to Overweight 02/01/21 Citi Citi opens 'Catalyst Watch' on McDonald's into chicken sandwich launch 01/21/21 UBS UBS sees 'golden' risk reward for McDonald's MRK Merck $72.37 / + (+0.00%) 02/25/21 SVB Leerink Pandion Therapeutics downgraded to Market Perform from Outperform at SVB Leerink 02/25/21 Morgan Stanley Pandion downgraded to Equal Weight from Overweight at Morgan Stanley 02/17/21 William Blair William Blair 'highly encouraged' by Nektar's collaborations with Merk, SFJ 01/21/21 Wedbush Scholar Rock price target raised to $66 from $47 at Wedbush BYND Beyond Meat $147.09 / -0.02 (-0.01%) 03/02/21 Citi Beyond Meat upgraded to Buy from Neutral at Citi 03/01/21 DA Davidson Beyond Meat price target raised to $145 from $133 at DA Davidson 02/26/21 Piper Sandler Beyond Meat relationship with McDonald's not much changed, says Piper Sandler TXMD TGT SOS SE RKT MRK MCD KOPN BYND TXMD TherapeuticsMD $1.44 / + (+0.00%) 03/02/21 TherapeuticsMD reports Q4 EPS (15c), consensus (10c) 11/09/20 TherapeuticsMD reports Q3 EPS (12c) with items, consensus (14c) 09/25/20 TherapeuticsMD says on track to meet or exceed Q3 revenue consensus of $15.1M TGT Target $186.12 / + (+0.00%) 03/02/21 Target reports Q4 adjusted EPS $2.67, consensus $2.54 03/01/21 Notable companies reporting before tomorrow's open 11/18/20 Target reports Q3 total revenue $22.63B, consensus $20.93B SOS SOS Limited $6.68 / + (+0.00%) 09/22/20 SOS clarifies shares purchase price of Tripartite Agreement SE Sea Limited $248.81 / + (+0.00%) 03/02/21 Sea Limited reports Q4 EPS (87c) ex-items, consensus (54c) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 11/17/20 Sea Limited reports Q3 EPS (38c), consensus (53c) RKT Rocket Companies $24.30 / + (+0.00%) 02/25/21 Rocket Companies reports Q4 adjusted EPS $1.14, consensus 87c 02/25/21 Notable companies reporting after market close 11/10/20 Rocket Companies sees Q4 closed loan volume $88B-93B 11/10/20 Rocket Companies reports Q3 EPS 54c, consensus $1.09 MRK Merck $72.37 / + (+0.00%) 02/04/21 Merck sees FY21 adjusted EPS $6.48-$6.68, consensus $6.41 02/04/21 Merck reports Q4 adjusted EPS $1.32, consensus $1.38 02/03/21 Notable companies reporting before tomorrow's open MCD McDonald's $208.25 / + (+0.00%) 01/28/21 McDonald's reports Q4 non-GAAP EPS $1.70, consensus $1.78 01/27/21 Notable companies reporting before tomorrow's open 11/09/20 McDonald's reports Q3 ex-items EPS $2.22, consensus $1.90 KOPN Kopin $9.14 / + (+0.00%) 11/03/20 Kopin reports Q3 EPS (1c), consensus (2c) BYND Beyond Meat $147.09 / -0.02 (-0.01%) 02/25/21 Beyond Meat reports Q4 adjusted EPS (34c), consensus (13c) 11/09/20 Beyond Meat reports Q3 adj. EPS (28c), consensus 5c 11/09/20 Notable companies reporting after market close 11 Feb 11 Dec 10 Nov 06 Aug XL TGT SE RKT MRK MCD BYND XL XL Fleet $14.87 / + (+0.00%) 12/23/20 XL Fleet jumps after Citron puts $60 price target on shares 12/23/20 Citron announces long position in XL Fleet with $60 price target TGT Target $186.12 / + (+0.00%) 02/26/21 Costco to hike minimum hourly wage to $16 an hour, WSJ reports 12/06/20 Chick-fil-A sues Tyson, others for poultry price-fixing, Bloomberg says 11/14/20 Targe booming during pandemic, stock still undervalued, Barron's says 10/24/20 Sprouts Farmers ready for rebound, Barron's says SE Sea Limited $248.81 / + (+0.00%) 01/14/21 Sea acquired majority control of Indonesian lender, Nikkei reports 12/10/20 Sea Limited to upsize deal by 20% to $2.57B priced at $195 per share, IFR says RKT Rocket Companies $24.30 / + (+0.00%) 10/01/20 Realtor.com announces new partnership with Rocket Mortgage, Inman reports MRK Merck $72.37 / + (+0.00%) 03/02/21 Merck to help produce J&J Covid vaccine, Washington Post reports 02/10/21 Merck in talks to produce authorized COVID-19 vaccines, WSJ says 02/03/21 Records show Merck's Propecia has trail of suicide reports, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says MCD McDonald's $208.25 / + (+0.00%) 02/28/21 McDonald's considering selling part of Dynamic Yield, Bloomberg reports 02/26/21 McDonald's clarifies to Bloomberg Beyond Meat's 'preferred supplier' status 02/09/21 Burger King testing loyalty program in five U.S. markets, CNBC reports 02/02/21 Judge rejects former McDonald's CEO's bid to dismiss lawsuit, Reuters reports BYND Beyond Meat $147.09 / -0.02 (-0.01%) 02/04/21 Lawsuit challenging FDA approval of Impossible color additive, FSN reports 02/01/21 McDonald's begins introduction of McPlant Burger in test markets, Bloomberg says 11/09/20 Beyond Meat up 4% after confirming partnership with McDonald's for 'McPlant' TXMD TGT SE RKT MRK MCD BYND TXMD TherapeuticsMD $1.44 / + (+0.00%) 02/10/21 Fly Intel: After-Hours Movers TGT Target $186.12 / + (+0.00%) 03/01/21 Fly Intel: What to watch in Target's earnings report 02/26/21 Fly Intel: Wall Street's top stories at midday 02/08/21 Target, Estee Lauder upgrades among today's top calls on Wall Street 01/13/21 Fly Intel: Wall Street's top stories for Wednesday SE Sea Limited $248.81 / + (+0.00%) 11/17/20 Fly Intel: Pre-market Movers RKT Rocket Companies $24.30 / + (+0.00%) 02/25/21 Fly Intel: After-Hours Movers 11/10/20 Fly Intel: After-Hours Movers 09/02/20 Fly Intel: After-Hours Movers MRK Merck $72.37 / + (+0.00%) 02/25/21 Fly Intel: Wall Street's top stories for Thursday 02/25/21 Fly Intel: Wall Street's top stories at midday 02/25/21 Fly Intel: Pre-market Movers 02/04/21 Fly Intel: Wall Street's top stories for Thursday MCD McDonald's $208.25 / + (+0.00%) 02/26/21 Fly Intel: Wall Street's top stories for Friday 02/25/21 Fly Intel: What to watch in Beyond Meat earnings report 01/27/21 Fly Intel: What to watch in McDonald's earnings report BYND Beyond Meat $147.09 / -0.02 (-0.01%) 03/01/21 Fly Intel: After-Hours Movers 02/26/21 Fly Intel: Pre-market Movers 04/09/21 Pharma/Biopharma 03/02/21 41st Annual Healthcare Virtual Conference 03/19/21 Electric Truck Day 03/02/21 Sea Limited - SE 03/02/21 Kopin - KOPN 03/02/21 TherapeuticsMD - TXMD 03/02/21 Target - TGT 03/30/21 XL Fleet - XL 04/29/21 Merck - MRK 03/29/21 PDUFA Date for KEYTRUDA 04/13/21 PDUFA Date for Keytrude w/Chemotherapy 07/18/21 PDUFA Date for V114 11/28/21 PDUFA Date for KEYTRUDA (Phase 3 KEYNOTE-355 Trial) 03/02/21 Target Corporation XL TXMD TGT SOS SE RKT MRK MCD BYND XL XL Fleet $14.87 / + (+0.00%) 03/01/21 XL Fleet call volume above normal and directionally bullish 02/12/21 XL Fleet call volume above normal and directionally bullish 02/09/21 XL Fleet call volume above normal and directionally bullish 01/26/21 Early notable gainers among liquid option names on January 26th TXMD TherapeuticsMD $1.44 / + (+0.00%) 10/27/20 Largest borrow rate increases among liquid names 10/06/20 Largest borrow rate increases among liquid names 09/16/20 Largest borrow rate increases among liquid names TGT Target $186.12 / + (+0.00%) 11/19/20 Early notable gainers among liquid option names on November 19th 11/17/20 Unusually active option classes on open November 17th SOS SOS Limited $6.68 / + (+0.00%) 03/01/21 Largest borrow rate increases among liquid names 03/01/21 SOS Limited put buyer realizes 222% same-day gains 01/12/21 Largest borrow rate increases among liquid names SE Sea Limited $248.81 / + (+0.00%) 02/01/21 Sea Limited call volume above normal and directionally bullish 01/28/21 Sea Limited call volume above normal and directionally bullish 01/08/21 Sea Limited call volume above normal and directionally bullish 12/29/20 Unusually active option classes on open December 29th RKT Rocket Companies $24.30 / + (+0.00%) 03/01/21 Rocket Companies call volume above normal and directionally bullish 03/01/21 Unusually active option classes on open March 1st 02/25/21 Rocket Companies options imply 18.1% move in share price post-earnings 02/19/21 Largest borrow rate increases among liquid names MRK Merck $72.37 / + (+0.00%) 02/17/21 Merck call volume above normal and directionally bullish 12/23/20 Merck call volume above normal and directionally bullish 10/20/20 Merck put volume heavy and directionally bearish MCD McDonald's $208.25 / + (+0.00%) 09/09/20 Unusually active option classes on open September 9th 09/02/20 McDonald's call volume above normal and directionally bullish BYND Beyond Meat $147.09 / -0.02 (-0.01%) 03/02/21 Largest borrow rate increases among liquid names 01/25/21 Beyond Meat call volume above normal and directionally bullish 01/22/21 Beyond Meat call volume above normal and directionally bullish 01/13/21 Largest borrow rate increases among liquid names
Periodicals	Merck to help produce J&J Covid vaccine, Washington Post reports » 08:03 03/02/21 03/02 08:03 03/02/21 08:03 MRK Merck $72.37 / -0.28 (-0.39%) , JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) President Biden will… President Biden will announce today that Merck (MRK) will help make Johnson & Johnson's (JNJ) single-shot coronavirus vaccine, Laurie McGinley and Christopher Rowland of Washington Post report, citing senior administration officials. Under the arrangement, Merck will dedicate two facilities in the United States to Johnson & Johnson's shots, officials told the paper. Reference Link ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MRK JNJ MRK Merck $72.37 / -0.28 (-0.39%) 03/01/21 Merck announces voluntary withdrawal for KEYTRUDA in SCLC 03/01/21 Merck: FDA accepts gefapixant New Drug Application for review 02/25/21 Merck to acquire Pandion Therapeutics for $60 per share in cash 02/25/21 Merck, Pandion Therapeutics deal has approx. total equity value of $1.85B JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) 02/28/21 Fly Intel: Top five weekend stock stories 02/28/21 CDC Advisory Committee recommends J&J single-shot COVID vaccine for adults 18+ 02/27/21 Johnson & Johnson Covid vaccine granted emergency approval from FDA 02/26/21 J&J confirms FDA panel recommends COVID-19 vaccine for EUA MRK JNJ MRK Merck $72.37 / -0.28 (-0.39%) 02/25/21 SVB Leerink Pandion Therapeutics downgraded to Market Perform from Outperform at SVB Leerink 02/25/21 Morgan Stanley Pandion downgraded to Equal Weight from Overweight at Morgan Stanley 02/17/21 William Blair William Blair 'highly encouraged' by Nektar's collaborations with Merk, SFJ 01/21/21 Wedbush Scholar Rock price target raised to $66 from $47 at Wedbush JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) 02/10/21 BTIG Model N upgraded to Buy from Neutral at BTIG 02/01/21 SVB Leerink Moderna price target raised to $80 from $69 at SVB Leerink 02/01/21 Wells Fargo Moderna price target raised to $145 from $129 at Wells Fargo 02/01/21 BofA BofA downgrades Moderna to Underperform, sees shares priced for 'best-case' MRK JNJ MRK Merck $72.37 / -0.28 (-0.39%) 02/04/21 Merck sees FY21 adjusted EPS $6.48-$6.68, consensus $6.41 02/04/21 Merck reports Q4 adjusted EPS $1.32, consensus $1.38 02/03/21 Notable companies reporting before tomorrow's open JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open MRK JNJ MRK Merck $72.37 / -0.28 (-0.39%) 02/10/21 Merck in talks to produce authorized COVID-19 vaccines, WSJ says 02/03/21 Records show Merck's Propecia has trail of suicide reports, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says 12/19/20 Alphabet, Apple among Barron's 10 Top stocks for 2021, Barron's says JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) 03/02/21 Johnson & Johnson Covid-19 vaccine shipments begin rollout, WSJ reports 02/26/21 FDA panel says J&J COVID-19 vaccine benefits outweigh risks, CNBC says 02/26/21 FDA advisory panel to review J&J's Covid-19 vaccine Friday, WSJ reports 02/25/21 Johnson & Johnson one-dose COVID-19 vaccine approved by Bahrain, Reuters says MRK JNJ MRK Merck $72.37 / -0.28 (-0.39%) 02/25/21 Fly Intel: Wall Street's top stories for Thursday 02/25/21 Fly Intel: Wall Street's top stories at midday 02/25/21 Fly Intel: Pre-market Movers 02/04/21 Fly Intel: Wall Street's top stories for Thursday JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) 03/01/21 Fly Intel: Wall Street's top stories for Monday 03/01/21 Fly Intel: Wall Street's top stories at midday 03/01/21 Fly Intel: Pre-market Movers 02/24/21 Fly Intel: Wall Street's top stories for Wednesday 03/05/21 Medical Technology 03/08/21 Biopharmaceuticals 04/09/21 Pharma/Biopharma 03/02/21 41st Annual Healthcare Virtual Conference 04/20/21 Johnson & Johnson - JNJ 04/29/21 Merck - MRK 03/29/21 PDUFA Date for KEYTRUDA 04/13/21 PDUFA Date for Keytrude w/Chemotherapy 07/18/21 PDUFA Date for V114 11/28/21 PDUFA Date for KEYTRUDA (Phase 3 KEYNOTE-355 Trial) MRK JNJ MRK Merck $72.37 / -0.28 (-0.39%) 02/17/21 Merck call volume above normal and directionally bullish 12/23/20 Merck call volume above normal and directionally bullish 10/20/20 Merck put volume heavy and directionally bearish JNJ Johnson & Johnson $159.34 / +0.92 (+0.58%) 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th 12/01/20 Johnson & Johnson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th

Monday
Hot Stocks	Merck announces voluntary withdrawal for KEYTRUDA in SCLC » 16:15 03/01/21 03/01 16:15 03/01/21 16:15 MRK Merck $72.37 / -0.28 (-0.39%) The company states: Merck… The company states: Merck announced the company is voluntarily withdrawing the U.S. indication for KEYTRUDA (pembrolizumab) for the treatment of patients with metastatic small cell lung cancer with disease progression on or after platinum-based chemotherapy and at least one other prior line of therapy. The withdrawal of this indication was done in consultation with the U.S. Food and Drug Administration, and Merck is working to complete this process over the coming weeks. This decision does not affect other indications for KEYTRUDA, Merck's anti-PD-1 therapy. This accelerated approval for KEYTRUDA was granted in June 2019 based on tumor response rate and durability of response data from KEYNOTE-158 and KEYNOTE-028. Continued approval for this indication was contingent upon completion of the post-marketing requirement establishing superiority of KEYTRUDA as determined by overall survival. As announced in Jan. 2020, KEYNOTE-604, the confirmatory Phase 3 trial for this indication, met one of its dual primary endpoints of progression-free survival but did not reach statistical significance for the other primary endpoint of OS. Merck's consultation with the FDA on this withdrawal is part of an industry-wide evaluation of indications based on accelerated approvals that have not yet met their post-marketing requirements. Merck is notifying health care professionals about this withdrawal. Patients being treated with KEYTRUDA for their metastatic SCLC should discuss their care with their health care provider." ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MRK Merck $72.37 / -0.28 (-0.39%) 03/01/21 Merck: FDA accepts gefapixant New Drug Application for review 02/25/21 Merck to acquire Pandion Therapeutics for $60 per share in cash 02/25/21 Merck, Pandion Therapeutics deal has approx. total equity value of $1.85B 02/25/21 Merck to acquire Pandion Therapeutics for $60 per share in cash MRK Merck $72.37 / -0.28 (-0.39%) 02/25/21 SVB Leerink Pandion Therapeutics downgraded to Market Perform from Outperform at SVB Leerink 02/25/21 Morgan Stanley Pandion downgraded to Equal Weight from Overweight at Morgan Stanley 02/17/21 William Blair William Blair 'highly encouraged' by Nektar's collaborations with Merk, SFJ 01/21/21 Wedbush Scholar Rock price target raised to $66 from $47 at Wedbush MRK Merck $72.37 / -0.28 (-0.39%) 02/04/21 Merck sees FY21 adjusted EPS $6.48-$6.68, consensus $6.41 02/04/21 Merck reports Q4 adjusted EPS $1.32, consensus $1.38 02/03/21 Notable companies reporting before tomorrow's open MRK Merck $72.37 / -0.28 (-0.39%) 02/10/21 Merck in talks to produce authorized COVID-19 vaccines, WSJ says 02/03/21 Records show Merck's Propecia has trail of suicide reports, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says 12/19/20 Alphabet, Apple among Barron's 10 Top stocks for 2021, Barron's says MRK Merck $72.37 / -0.28 (-0.39%) 02/25/21 Fly Intel: Wall Street's top stories for Thursday 02/25/21 Fly Intel: Wall Street's top stories at midday 02/25/21 Fly Intel: Pre-market Movers 02/04/21 Fly Intel: Wall Street's top stories for Thursday 04/09/21 Pharma/Biopharma 03/02/21 41st Annual Healthcare Virtual Conference 04/29/21 Merck - MRK 03/29/21 PDUFA Date for KEYTRUDA 04/13/21 PDUFA Date for Keytrude w/Chemotherapy 07/18/21 PDUFA Date for V114 11/28/21 PDUFA Date for KEYTRUDA (Phase 3 KEYNOTE-355 Trial) MRK Merck $72.37 / -0.28 (-0.39%) 02/17/21 Merck call volume above normal and directionally bullish 12/23/20 Merck call volume above normal and directionally bullish 10/20/20 Merck put volume heavy and directionally bearish
Recommendations	Bayer price target lowered to EUR 66 from EUR 68 at Morgan Stanley » 15:19 03/01/21 03/01 15:19 03/01/21 15:19 BAYRY Bayer $0.00 / + (+0.00%) Morgan Stanley analyst… Morgan Stanley analyst James Quigley lowered the firm's price target on Bayer to EUR 66 from EUR 68 and keeps an Overweight rating on the shares. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly BAYRY Bayer $0.00 / + (+0.00%) 02/24/21 Bayer to divest Environmental Science Professional business 02/17/21 Selecta, AskBio initiate first-in-human dose escalation study of ImmTOR 02/05/21 CureVac enters pact with UK Government to develop SARS-CoV-2 variant vaccine 02/03/21 Bayer announes $2B agreement to resolve future Roundup cases BAYRY Bayer $0.00 / + (+0.00%) 02/26/21 Credit Suisse Bayer price target raised to EUR 56 from EUR 55 at Credit Suisse 02/10/21 Barclays Bayer price target raised to EUR 55 from EUR 50 at Barclays 02/04/21 Citi opens positive 'Catalyst Watch' on Bayer 01/27/21 Deutsche Bank Bayer price target raised to EUR 63 from EUR 62 at Deutsche Bank BAYRY Bayer $0.00 / + (+0.00%) 02/25/21 Bayer sees 2021 core EPS approx. EUR5.60-EUR5.80 02/25/21 Bayer reports Q4 core EPS EUR1.32 vs. EUR1.44 last year 11/03/20 Bayer confirms FY20 targets, sees core EPS EUR6.70-EUR6.90 11/03/20 Bayer reports Q3 core EPS down 30.2% to EUR0.81 BAYRY Bayer $0.00 / + (+0.00%) 01/06/21 CureVac, Bayer reach alliance deal over COVID-19 vaccine, Reuters says 10/27/20 EPA clears use of Bayer's XtendiMax for five years, Reuters reports 10/11/20 Bayer, BASF fighting to keep weedkiller on U.S. farms, WSJ reports 09/15/20 Bayer resolves thousands of U.S. Roundup cases with trial lawyers, Reuters says BAYRY Bayer $0.00 / + (+0.00%) 01/07/21 Fly Intel: Pre-market Movers 09/30/20 Fly Intel: Wall Street's top stories for Wednesday 09/29/20 Fly Intel: Wall Street's top stories for Tuesday

On The Fly

News and insights, exclusive to thefly.com

13:23	Notable companies reporting after market close»
11:37	Roth boosts Ocugen target after partnered vaccine shows 'broad' efficacy»
11:33	Washington Prime falls after Bloomberg says preparing bankruptcy filing»
09:55	Fly Intel: Top five analyst initiations»
09:55	Fly Intel: Top five analyst downgrades»

View all On The Fly Stories »

Upcoming
Events (10)

	14th OPEC and non-OPEC Ministerial Meeting
CLNN	Clene - CLNN
LCII	LCI Industries - LCII
	Microsoft Ignite
ANGI ...	Real Estate Technology Virtual Conference
	Asia Online Education Virtual Seminar
	2021 London Global Healthcare Virtual Conference
AGRX ...	M-Vest Virtual Conference Series: Late Stage Innovations in Women's Health
	2021 Virtual Sustainability Conference
BAC ...	Bank and Tech Pop Up Virtual Conference

View all of today’s events »

Today’s
Syndicate (0)

No syndicate deals for your search.

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial